Emtora Biosciences: Emtora Biosciences Presents Phase Ib Data in Low Grade Prostate Cancer Patients at the 2020 ASCOSITC Clinical ImmunoOncology Symposium

Emtora Biosciences a privatelyheld clinical stage life science company developing eRapaTM for the prevention of cancer progression today announced a poster presentation at the American Society of Clinical Oncology ASCO and Society for Immunotherapy of Canc...